Copyright © Inderes 2011 - present. All rights reserved.

Nexstim

11.70 EUR

+3.54 %

5,620 following
Corporate customer

NXTMH

First North Finland

Medical Equipment & Services

Health Care

+3.54 %
-10.00 %
-17.61 %
-20.68 %
-20.95 %
+46.62 %
+195.45 %
+53.11 %
-98.07 %

Nexstim operates in medical technology. The company has developed a non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with 3D navigation providing targeting of the TMS to the specific area of the brain. The technology is aimed for the treatment of major depression and chronic neuropathic pain. The company was founded in 2000 and has its headquarters in Helsinki.

Read more
Market cap
84.4M EUR
Turnover
37.55K EUR
P/E (adj.) (25e)
66.93
EV/EBIT (adj.) (25e)
61.17
P/B (25e)
16.64
EV/S (25e)
7.21
Dividend yield-% (25e)
-
Coverage
Recommendation
Reduce
Target price
12.00 EUR
Updated
04.01.2026
Disclaimer
Antti Siltanen
Antti Siltanen

Analyst

Latest research

Latest analysis report

Released: 05.01.2026

Latest extensive report

Released: 26.06.2025

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26.2
2026

Annual report '25

30.3
2026

General meeting '26

14.8
2026

Interim report Q2'26

Risk
Business risk
Valuation risk
Low
High
ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
Spotted on Kauppalehti’s website that there’s one guy looking to get rid of his shares. Since the trading volume is low and he has a lot of shares, the price inevitably drops. Add to this other panicking retail investors who sell just because the price is sliding. I don’t believe...
2/12/2026, 4:12 PM
by MagnificRat
15
The part attached to the head, used for instance in therapy treatments, has been made reusable based on customer feedback. Apparently license-based pricing. linkedin.com The re-usable head tracker is here! | Nexstim Did you know? With the release of our NBS 6 we’ve just expanded ...
2/11/2026, 3:06 PM
by Tsemi
9
Fresh research with Nexstim’s TMS-EEG. Precision is increasing, and it may open up more opportunities in the future. If anyone on this forum is more familiar with the field, perhaps they could provide a slightly more detailed interpretation of the study for us laypeople. In any case...
2/3/2026, 5:26 PM
by Jatast
9
Now that AI is disrupting almost all industries across the board, the question arises as to how this will affect Nexstim’s business. I’ve been mulling over various scenarios, but I can’t easily come up with any dramatic angle where AI would reduce the need for Nexstim’s devices. ...
yesterday
by Mark_Renton
8
That is a good improvement; even though the new model might be worse business for Nexstim, it still feels stupid to throw away a plastic gadget of that size after every use. Here is also a link to a page where negative feedback was given on the subject. “Sadly, they don’t have a ...
2/12/2026, 7:20 AM
by ghoul
6
If you’re bored, you can browse clinics there that have Nexstim’s equipment or see whose devices are where. TMS List United States - TMS Clinics Find FDA-cleared TMS therapy clinics near you. Compare verified providers, read reviews, and start your depression treatment journey.
2/11/2026, 1:39 PM
by Jatast
6
MedTech World Middle East, taking place from 11 to 13 February https://med-tech.world/news/meet-startups-and-exhibitors-medtech-world-middle-east-dubai-2026/ Sinaptica has its own “booth” in Dubai.
2/3/2026, 5:35 PM
by Jatast
6
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.